Palomino Laboratories Inc (PALX)

On April 20, 2026, Palomino Laboratories Inc recorded two significant insider acquisitions. Secretary Richard Ogawa and Steven Denbaars each purchased 12,500 shares, totaling 50,000 dollars per individual. These transactions represent the most recent activity observed for the firm, occurring over three months ago.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: PALX Exchange: PNK

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Palomino Laboratories Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Ogawa Richard Secretary Executive Director

Transaction date 20 Apr 2026

Purchase

Price

482.95

Quantity 69,517 -41.2%

Value US$1,828,394

3.2

Denbaars Steven Non-Executive Director

Transaction date 20 Apr 2026

Purchase

Price

463.02

Quantity 2,307 -12.1%

Value US$170,268

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-04-20	2026-04-20	B Purchase	Ogawa Richard Secretary Executive Director	69,517 -41.2% 482.95 US$1,828,394	69,517 -41.2%	482.95	US$1,828,394
2026-04-20	2026-04-20	B Purchase	3.2 Denbaars Steven Non-Executive Director	2,307 -12.1% 463.02 US$170,268	2,307 -12.1%	463.02	US$170,268